- Home
- EPM vs CRVO Comparison
EPM vs CRVO Comparison
Compare EPM & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- CRVO
- Stock Information
- Founded
- EPM 2003
- CRVO 2001
- Country
- EPM United States
- CRVO United States
- Employees
- EPM N/A
- CRVO N/A
- Industry
- EPM Oil & Gas Production
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- EPM Energy
- CRVO Health Care
- Exchange
- EPM Nasdaq
- CRVO Nasdaq
- Market Cap
- EPM 169.0M
- CRVO 98.3M
- IPO Year
- EPM 1996
- CRVO N/A
- Fundamental
- Price
- EPM $5.51
- CRVO $2.13
- Analyst Decision
- EPM Strong Buy
- CRVO Buy
- Analyst Count
- EPM 1
- CRVO 8
- Target Price
- EPM $8.25
- CRVO $38.75
- AVG Volume (30 Days)
- EPM 216.5K
- CRVO 476.7K
- Earning Date
- EPM 02-04-2025
- CRVO 11-12-2024
- Dividend Yield
- EPM 8.78%
- CRVO N/A
- EPS Growth
- EPM N/A
- CRVO N/A
- EPS
- EPM 0.14
- CRVO N/A
- Revenue
- EPM $87,172,000.00
- CRVO $10,066,550.00
- Revenue This Year
- EPM $7.51
- CRVO $34.17
- Revenue Next Year
- EPM N/A
- CRVO N/A
- P/E Ratio
- EPM $38.97
- CRVO N/A
- Revenue Growth
- EPM N/A
- CRVO 116.29
- 52 Week Low
- EPM $4.59
- CRVO $1.80
- 52 Week High
- EPM $6.29
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- EPM 58.92
- CRVO 28.45
- Support Level
- EPM $5.25
- CRVO $1.99
- Resistance Level
- EPM $5.46
- CRVO $2.43
- Average True Range (ATR)
- EPM 0.14
- CRVO 0.17
- MACD
- EPM 0.05
- CRVO 0.31
- Stochastic Oscillator
- EPM 97.18
- CRVO 26.92
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the United States. It is engaged predominantly in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are generated from its crude oil, natural gas, and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.